Kema IP - Search Results

1

Iodine-123 metaiodobenzylguanidine scintigraphy in localising phaeochromocytomas--experience and meta-analysis.

Van Der Horst-Schrivers AN, Jager PL, Boezen HM, Schouten JP, Kema IP, Links TP. Van Der Horst-Schrivers AN, et al. Among authors: kema ip. Anticancer Res. 2006 Mar-Apr;26(2B):1599-604. Anticancer Res. 2006. PMID: 16619578 Free article.

2

L-3-[123I]Iodo-alpha-methyltyrosine scintigraphy in carcinoid tumors: correlation with biochemical activity and comparison with [111In-DTPA-D-Phe1]-octreotide imaging.

Jager PL, Meijer WG, Kema IP, Willemse PH, Piers DA, de Vries EG. Jager PL, et al. Among authors: kema ip. J Nucl Med. 2000 Nov;41(11):1793-800. J Nucl Med. 2000. PMID: 11079485 Free article.

3

Catecholamine-synthesizing enzymes in carcinoid tumors and pheochromocytomas.

Meijer WG, Copray SC, Hollema H, Kema IP, Zwart N, Mantingh-Otter I, Links TP, Willemse PH, de Vries EG. Meijer WG, et al. Among authors: kema ip. Clin Chem. 2003 Apr;49(4):586-93. doi: 10.1373/49.4.586. Clin Chem. 2003. PMID: 12651811

4

Complications of midgut carcinoid tumors and carcinoid syndrome.

van der Horst-Schrivers AN, Wymenga AN, Links TP, Willemse PH, Kema IP, de Vries EG. van der Horst-Schrivers AN, et al. Among authors: kema ip. Neuroendocrinology. 2004;80 Suppl 1:28-32. doi: 10.1159/000080737. Neuroendocrinology. 2004. PMID: 15477713 Review.

5

Carcinoid crisis after injection of 6-18F-fluorodihydroxyphenylalanine in a patient with metastatic carcinoid.

Koopmans KP, Brouwers AH, De Hooge MN, Van der Horst-Schrivers AN, Kema IP, Wolffenbuttel BH, De Vries EG, Jager PL. Koopmans KP, et al. Among authors: kema ip. J Nucl Med. 2005 Jul;46(7):1240-3. J Nucl Med. 2005. PMID: 16000294 Free article.

6

Clinical utility of an automated immunochemiluminometric thyroglobulin assay in differentiated thyroid carcinoma.

Persoon AC, Van Den Ouweland JM, Wilde J, Kema IP, Wolffenbuttel BH, Links TP. Persoon AC, et al. Among authors: kema ip. Clin Chem. 2006 Apr;52(4):686-91. doi: 10.1373/clinchem.2005.060095. Clin Chem. 2006. PMID: 16595825

7

Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study.

Koopmans KP, de Vries EG, Kema IP, Elsinga PH, Neels OC, Sluiter WJ, van der Horst-Schrivers AN, Jager PL. Koopmans KP, et al. Among authors: kema ip. Lancet Oncol. 2006 Sep;7(9):728-34. doi: 10.1016/S1470-2045(06)70801-4. Lancet Oncol. 2006. PMID: 16945767

8

Biochemical markers in the follow-up of medullary thyroid cancer.

de Groot JW, Kema IP, Breukelman H, van der Veer E, Wiggers T, Plukker JT, Wolffenbuttel BH, Links TP. de Groot JW, et al. Among authors: kema ip. Thyroid. 2006 Nov;16(11):1163-70. doi: 10.1089/thy.2006.16.1163. Thyroid. 2006. PMID: 17123344

9

Plasma free metanephrine measurement using automated online solid-phase extraction HPLC tandem mass spectrometry.

de Jong WH, Graham KS, van der Molen JC, Links TP, Morris MR, Ross HA, de Vries EG, Kema IP. de Jong WH, et al. Among authors: kema ip. Clin Chem. 2007 Sep;53(9):1684-93. doi: 10.1373/clinchem.2007.087114. Clin Chem. 2007. PMID: 17712005

10

Persistent low urinary excretion of 5-HIAA is a marker for favourable survival during follow-up in patients with disseminated midgut carcinoid tumours.

van der Horst-Schrivers AN, Post WJ, Kema IP, Links TP, Willemse PH, Wymenga AN, de Vries EG. van der Horst-Schrivers AN, et al. Among authors: kema ip. Eur J Cancer. 2007 Dec;43(18):2651-7. doi: 10.1016/j.ejca.2007.07.025. Epub 2007 Sep 6. Eur J Cancer. 2007. PMID: 17825550

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

350 results

Search Page

Filters